|
Company
Roster
|
Total
Insiders : |
29 |
|
|
Total
Direct Shares :
|
23,649,271 |
|
Total
Indirect Shares :
|
4,792,534 |
|
%
Held by Insiders:
|
20.66% |
|
|
|
Filer's Name |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Aju Ib Investment Co., Ltd. |
10% Owner |
2017-11-13 |
0 |
2017-11-13 |
2,292,062 |
Sadr Ahmad |
See Remarks |
2020-02-10 |
2,725 |
2020-02-10 |
0 |
Perry Nicole D |
Vice President - Accounting |
2021-08-02 |
4,847 |
|
0 |
Celona Lucia |
See Remarks |
2020-02-10 |
5,213 |
2020-02-10 |
0 |
Lackner Thomas A. |
See Remarks |
2020-02-10 |
7,725 |
|
0 |
Chan Gerald |
Director |
2024-01-01 |
11,438 |
|
0 |
Obrien Stephanie Monaghan |
Director |
2024-01-01 |
11,438 |
|
0 |
Fonteyne Paul R. |
Director |
2024-01-01 |
16,438 |
2020-05-08 |
0 |
Brown Victoria L. |
Program Team Lead |
2023-01-20 |
23,556 |
|
0 |
Chopas James George |
VP/Chief Accounting Officer |
2024-03-15 |
38,883 |
2021-08-30 |
0 |
Lewis Karen |
Chief People Officer |
2024-01-30 |
46,387 |
2021-01-28 |
0 |
Axon Steven |
Chief Business Officer |
2018-11-14 |
50,110 |
2018-02-20 |
0 |
Delong Mark Jeffrey |
Chief Business & Strat Officer |
2024-03-18 |
54,693 |
|
0 |
Nicholson Nur |
Chief Technical Officer |
2024-03-13 |
56,287 |
2021-01-28 |
0 |
Eisele Jeffrey |
Chief Development Officer |
2024-01-30 |
57,208 |
2020-12-23 |
0 |
Baumal Caroline |
Chief Medical Officer |
2024-01-16 |
58,376 |
2023-01-03 |
0 |
Scheibler Lukas |
Chief Research Officer |
2023-12-01 |
68,299 |
2018-05-24 |
0 |
Sullivan Timothy Eugene |
|
2024-04-18 |
79,174 |
2024-04-18 |
70,396 |
Townsend Adam J. |
Chief Commercial Officer |
2024-02-12 |
92,453 |
2020-02-10 |
0 |
Grossi Federico |
Chief Medical Officer |
2023-01-05 |
94,884 |
2018-04-11 |
0 |
Watson David O. |
General Counsel |
2024-03-06 |
107,152 |
2024-03-06 |
90,705 |
Dunlop A. Sinclair |
Director |
2024-04-12 |
133,518 |
2024-04-12 |
205,853 |
Francois Cedric |
Chief Executive Officer, Director |
2024-03-01 |
313,662 |
2024-03-01 |
1,721,568 |
Machiels Alec |
Director |
2024-01-01 |
370,761 |
2024-01-01 |
411,950 |
Gellert Michael E |
10% Owner |
2017-11-13 |
943,989 |
2017-11-13 |
0 |
Deschatelets Pascal |
Chief Scientific Officer |
2024-05-20 |
1,140,483 |
2018-05-07 |
0 |
Cormorant Global Healthcare Master Fund, Lp |
10% Owner |
2017-11-13 |
3,473,925 |
2017-11-13 |
0 |
Venbio Global Strategic Fund Ii L.p. |
10% Owner |
2017-11-13 |
3,579,305 |
2017-11-13 |
0 |
Morningside Venture Investments Ltd |
10% Owner |
2021-11-18 |
12,806,342 |
2017-11-13 |
0 |
|